Lidocaine Base is a white, crystalline powder acting as a potent amide-type local anaesthetic and anti-arrhythmic drug, commonly used as an active pharmaceutical ingredient in topical creams, gels, and patches to relieve pain, itching, or soreness. Lidocaine Base Manufacturers supplying this API to regulated pharmaceutical markets know that a compound this widely formulated leaves no room for inconsistency in purity levels, particle size, and related substance profiles, all of which feed directly into how the finished product performs. Silverline Chemicals produces Lidocaine Base under documented manufacturing conditions, with every batch tested and cleared before it is released for dispatch.
With the molecular formula C₁₄H₂₂N₂O and a molecular weight of 234.34 g/mol, Lidocaine Base differs from Lidocaine Hydrochloride in its free base form, making it the preferred choice in formulations where the hydrochloride salt's water solubility is not required, particularly in lipophilic bases such as topical creams, transdermal patches, and oil-based preparations. Its amide-class chemistry gives it a more stable metabolic profile and a lower sensitisation risk compared to ester-type local anaesthetics.
Product Overview:
|
Parameter |
Details |
|
Chemical Name |
Lidocaine Base |
|
Molecular Formula |
C₁₄H₂₂N₂O |
|
Molecular Weight |
234.34 g/mol |
|
CAS Number |
137-58-6 |
|
Appearance |
White crystalline powder |
|
Purity |
99% minimum |
|
Solubility |
Slightly soluble in water; freely soluble in alcohol |
|
Grade |
Pharmaceutical Grade |
|
Packaging |
1 kg, 5 kg, 25 kg aluminium foil bags in fibre drums |
Formulation teams working with it in validated processes understand that switching API sources mid-development is not a straightforward exercise. Dissolution profiles, skin penetration rates, and stability data are all tied to the physical characteristics of the specific batch around which the formulation was built. That is exactly why sourcing directly from Lidocaine Base Manufacturers in India matters more for this compound than for many others.
Procuring directly means batch-specific data particle size distribution, related substance profiles, and purity confirmation reflect the actual lot being purchased. CoA, MSDS, and pharmacopoeial compliance documentation are supplied as standard, with aluminium foil-lined fibre drum packaging maintaining compound integrity through transit and storage.
Lidocaine Base Suppliers in India serving topical formulation developers, transdermal patch manufacturers, dental product producers, hospital product manufacturers, and contract pharmaceutical organisations across the country. The supply range covers both small development quantities for formulation and stability work, and large commercial volumes for established product lines handled under the same pharmaceutical grade specification and documentation standard, regardless of order size.
Lidocaine Base Manufacturers in India continue to see consistent demand for this API form across multiple formulation categories, and the clinical and pharmaceutical reasons behind that demand are well-grounded.
The free base form fits directly into lipophilic systems, creams, ointments, transdermal patches, and oil-based preparations, where the hydrochloride salt's solubility profile tends to complicate rather than contribute.
As an amide-class compound, it follows a more predictable metabolic route with fewer hypersensitivity concerns than ester alternatives, a meaningful distinction for consumer-facing topical products.
Onset is rapid and localised, keeping effective API concentrations low across both clinical and consumer applications.
Pharmacopoeial coverage across USP, BP, and EP significantly reduces the regulatory workload for manufacturers entering new markets.
Decades of documented use across injectable, topical, and transdermal categories mean the safety and efficacy groundwork is already established, making product registrations considerably more straightforward.
Broad compatibility with excipients and base systems keeps formulation development manageable when building new topical or transdermal product lines.
Local anaesthetic APIs carry specific import regulations across most markets, and documentation gaps at customs create delays that feed directly into production disruptions. As renowned Lidocaine Base Exporters in India, shipments across the Middle East, Southeast Asia, Africa, and South Asia are prepared with destination-market compliance built in from the start, not addressed after freight has already moved.
Export documentation, CoA, MSDS, commercial invoice, packing list, and any country-specific import compliance papers are verified before carriers are engaged. Pharmaceutical cargo handling experience is a consistent requirement in carrier selection.
To source for your formulation pipeline, reach out to our team with volume and specification requirements for prompt pricing, grade details, and lead time confirmation.